LLYon logo

Eli Lilly and Company (LLY)

Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally. The company offers cardiometabolic health products, including Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insul...

NYSEHealthcareDrug Manufacturers - GeneralUSA

公司簡介

股票程式碼
LLY
ISIN程式碼
US5324571083
貨幣
US Dollar (USD)
IPO日期
1978-01-13

聯絡資訊

公司地址
Lilly Corporate Center, Indianapolis, IN, United States, 46285
聯絡電話
317 276 2000
公司網站
https://www.lilly.com
財年結束
December

財務亮點

市值
$999,999.99
毛利潤(TTM)
$999,999.99
股息收益率
0.61%
資產回報率(TTM)
20.74%
EBITDA
$999,999.99
收入(TTM)
$999,999.99